SPRINGFIELD – The Cannabis Business Association of Illinois released the following statement after President Joe Biden announced his administration took a key step forward to reclassify marijuana from a Schedule I to a Schedule III drug:
“We applaud the Biden administration’s decision to reclassify marijuana under the Controlled Substances Act as it affirms what our group advocates for – safe, legal, and community-building uses of cannabis. We look forward to evaluating the proposed rules, which would reclassify marijuana from a Schedule I drug on par with heroin to a less dangerous Schedule III drug,” said Tiffany Chappell Ingram, Executive Director of the Cannabis Business Association of Illinois. “In the decades since marijuana was erroneously categorized, Black and Brown communities have experienced countless repercussions stemming from the war on drugs. While this decision cannot reverse that damage, it does recognize the medical benefits of cannabis and enhances the viability of marijuana companies, including allowing for the same expense deductions enjoyed by other businesses. This is an important step in the right direction for the cannabis industry and our society at large, and we hope this continues to pave the path towards federal legalization.”
About the Cannabis Business Association of Illinois (CBAI)
The Cannabis Business Association of Illinois serves as the voice of Illinois’ cannabis industry by advocating for patient well-being, consumer safety, greater equity and inclusion, job creation, community investment and the responsible use of cannabis. CBAI is a non-profit association that represents Illinois cannabis businesses licensed by the state of Illinois, as well as ancillary businesses that support the cannabis industry and social equity applicants. For more information, visit www.cbail.org.